| |
| |
|
| Insider
Information: |
Kotler Kevin |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
21,110,942 |
|
|
Indirect Shares
|
14,999,978 |
|
|
| Direct
Value |
$275,607,835 |
|
|
|
Indirect Value
|
$26,106,564 |
|
|
| Total
Shares |
36,110,920 |
|
|
| Total
Value |
$301,714,399 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Progenics Pharmaceuticals Inc |
PGNX |
10% Owner |
2017-02-15 |
6,997,269 |
2014-07-16 |
0 |
Premium* |
|
|
Societal CDMO, Inc |
SCTL |
10% Owner |
2018-05-24 |
2,048,025 |
2014-12-02 |
0 |
Premium* |
|
|
Travere Therapeutics, Inc |
TVTX |
10% Owner |
2015-01-13 |
2,658,854 |
|
0 |
Premium* |
|
|
Strata Skin Sciences Inc |
SSKN |
10% Owner |
2016-03-11 |
1,008,297 |
2015-08-11 |
1,274,297 |
Premium* |
|
|
Dextera Surgical Inc |
DXTR |
10% Owner |
|
0 |
2015-09-04 |
8,874,992 |
Premium* |
|
|
Aegerion Pharmaceuticals, Inc. |
AEGR |
10% Owner |
2016-11-29 |
0 |
2015-11-11 |
0 |
Premium* |
|
|
AVADEL Pharmaceuticals Plc |
AVDL |
10% Owner |
2017-06-23 |
4,133,464 |
|
0 |
Premium* |
|
|
Aratana Therapeutics, Inc. |
PETX |
10% Owner |
2019-07-18 |
0 |
|
0 |
Premium* |
|
|
Corium International, Inc. |
CORI |
10% Owner |
2018-11-27 |
0 |
2017-10-04 |
0 |
Premium* |
|
|
Mirati Therapeutics, Inc. |
MRTX |
10% Owner |
2017-11-16 |
2,728,601 |
2017-11-16 |
0 |
Premium* |
|
|
Novelion Therapeutics Inc |
NVLN |
10% Owner |
2018-12-27 |
1,498,553 |
2018-12-24 |
0 |
Premium* |
|
|
Biodelivery Sciences Internation... |
BDSI |
Director |
2019-04-11 |
0 |
2020-03-17 |
4,310,689 |
Premium* |
|
|
Heron Therapeutics Inc |
HRTX |
Director |
2023-02-22 |
37,879 |
2023-02-22 |
540,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
66 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AEGR |
Aegerion Pharmaceuticals,... |
10% Owner |
– – • |
2016-11-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,361,291) |
0 |
0 |
- |
|
| CORI |
Corium International, Inc... |
10% Owner |
– – • |
2018-11-27 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,474,995) |
0 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
10% Owner |
– – • |
2019-07-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,258,135) |
0 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2023-02-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
37,879 |
|
% |
|
| BDSI |
Biodelivery Sciences Inte... |
Director |
– • – |
2019-11-18 |
4 |
S |
$5.90 |
$10,584,165 |
I/I |
(1,793,757) |
300,066 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2023-02-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
540,000 |
|
% |
|
| SSKN |
Strata Skin Sciences Inc |
10% Owner |
– – • |
2016-03-11 |
4 |
S |
$1.05 |
$272,800 |
D/D |
(216,000) |
1,008,297 |
0 |
- |
|
| SSKN |
Strata Skin Sciences Inc |
10% Owner |
– – • |
2016-03-10 |
4 |
S |
$1.50 |
$75,015 |
D/D |
(50,000) |
1,224,297 |
0 |
- |
|
| SSKN |
Strata Skin Sciences Inc |
10% Owner |
– – • |
2015-08-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,274,297 |
|
- |
|
| SSKN |
Strata Skin Sciences Inc |
10% Owner |
– – • |
2015-08-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,274,297 |
|
- |
|
| SCTL |
Societal CDMO, Inc |
10% Owner |
– – • |
2014-12-02 |
4 |
B |
$2.50 |
$603,345 |
D/D |
241,338 |
1,413,533 |
2.45 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
10% Owner |
– – • |
2018-12-27 |
4 |
S |
$0.85 |
$146,307 |
D/D |
(171,116) |
1,498,553 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
10% Owner |
– – • |
2018-12-26 |
4 |
S |
$0.87 |
$254,715 |
D/D |
(278,485) |
1,669,669 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
10% Owner |
– – • |
2018-12-24 |
4 |
S |
$0.98 |
$392 |
D/D |
(400) |
1,948,154 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
10% Owner |
– – • |
2018-05-24 |
4 |
S |
$5.51 |
$1,093,182 |
D/D |
(188,000) |
2,048,025 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
10% Owner |
– – • |
2015-07-07 |
4 |
B |
$11.60 |
$7,500,015 |
D/D |
646,553 |
2,060,086 |
2.45 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
Director |
– • – |
2019-11-15 |
4 |
S |
$6.04 |
$13,319,089 |
I/I |
(2,206,243) |
2,093,823 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
10% Owner |
– – • |
2018-03-13 |
4 |
S |
$10.07 |
$2,014,000 |
D/D |
(200,000) |
2,236,025 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
Director |
– • – |
2019-12-20 |
4 |
S |
$6.32 |
$6,320,000 |
I/I |
(1,000,000) |
2,300,066 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
10% Owner |
– – • |
2017-12-21 |
4 |
S |
$9.80 |
$500,240 |
D/D |
(51,000) |
2,436,025 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
10% Owner |
– – • |
2016-08-16 |
4 |
B |
$7.50 |
$2,925,000 |
D/D |
390,000 |
2,450,086 |
2.45 |
- |
|
| SCTL |
Societal CDMO, Inc |
10% Owner |
– – • |
2017-12-20 |
4 |
S |
$10.00 |
$250,000 |
D/D |
(25,000) |
2,487,025 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
10% Owner |
– – • |
2017-12-13 |
4 |
S |
$9.80 |
$178,139 |
D/D |
(18,137) |
2,512,025 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
10% Owner |
– – • |
2017-12-12 |
4 |
S |
$9.80 |
$740,989 |
D/D |
(75,100) |
2,530,162 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
10% Owner |
– – • |
2017-12-05 |
4 |
S |
$10.00 |
$1,000,000 |
D/D |
(100,000) |
2,605,262 |
0 |
- |
|
66 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
